Delivery Order SPE2DB22D9367-SPE2DB25FSZ61
- Not listed
- The Defense Logistics Agency awarded a $26,038.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 19, 2025, for Mirena 52 mg systems, with an ultimate completion date of October 10, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge facility. This delivery order was issued without a set-aside designation, allowing the vendor to compete on an unrestricted...
- The Defense Logistics Agency awarded a delivery order valued at $29,163.12 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was issued without a set-aside designation on July 29, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, Illinois. This delivery order...
- The Defense Logistics Agency awarded a $6,249.24 delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of October 8, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order operates under a firm fixed-price contract type, with performance taking place at the contractor's Park Ridge, Illinois facility. This...
- The Defense Logistics Agency awarded a $5,207.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of September 8, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be performed at the contractor's facility in Park Ridge, IL 60068. This delivery order is issued under DMS...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is set for ultimate completion by August 12, 2025, and represents a discrete purchase under the company's existing relationship with the DLA. This...
- The Defense Logistics Agency awarded a $3,124.68 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of October 9, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be performed at the contractor's location in Park Ridge, Illinois. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a $7,290.78 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of August 6, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be performed at the contractor's Park Ridge facility and represents a discrete purchase under the company's broader...
- The Defense Logistics Agency awarded a $10,415.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of October 9, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be fulfilled at the contractor's location in Park Ridge, Illinois. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $3,124.68 to DMS Pharmaceutical Group Inc. for the supply of Mirena 52 mg systems. The award, made on August 14, 2025, with an ultimate completion date of September 5, 2025, utilizes a firm fixed-price contract type with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected as the prime contractor for this delivery order. This...
- The Defense Logistics Agency awarded a delivery order valued at $15,623.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mirena 52 mg systems. This firm fixed-price delivery order, issued on July 18, 2025, with an ultimate completion date of August 8, 2025, represents a continuation of DMS Pharmaceutical Group's substantial role as a pharmaceutical supplier to the Department of Defense. The award...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB25FSZ61Delivery Order
The Defense Logistics Agency awarded a $31,246.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with a completion date of September 24, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery will be performed at the contractor's Park Ridge facility and represents a continuation of the agency's pharmaceutical supply chain operations. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion vehicle valid through November 2026. The IDC enables the Defense Logistics Agency to procure a comprehensive range of pharmaceutical products, including prescription medications, biologics, and medical consumables, to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a significant federal pharmaceutical supplier through consistent contract performance across diverse medical product categories, leveraging its woman-owned small business status to compete effectively in federal procurement markets.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.2k | 9/3/25 |